跳至主要内容
临床试验/NL-OMON56338
NL-OMON56338尚未招募不适用

Diffuse reflectance spectroscopy measurements during a ultrasound guided vacuum assisted excision procedure of breast tumors - Minimal invasive breast cancer treatment

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Major inclusion criteria BCS patients phase 1:
  • Woman, >= 18 years old
  • Histology proven invasive ductal carcinoma of the breast planned for BCS
  • Lesion visible on ultrasound
  • Lesions size <= 25 mm on MRI and US
  • No associated mammographic microcalcifications outside the lesion
  • Lesion >= 6mm distance from dermis, nipple or pectoral muscle
  • Normal axillary ultrasound
  • Written informed consent
  • Major inclusion criteria mastectomy patients phase 1:
  • Woman, >= 18 years old
  • Histology proven invasive ductal carcinoma of the breast planned for
  • Lesion visible on ultrasound
  • Lesions size <= 25 mm on MRI and US
  • Written informed consent
  • Major inclusion criteria for phase 2 are the same as phase 1 (patients
  • scheduled for BCS) with an additional inclusion criterium:
  • Patients with invasive ductal carcinomas only and an ERpos /HER2neg tumor

排除标准

  • Neo-adjuvant chemotherapy treatment
  • Poor ultrasound visibility of the lesion
  • Patients with breast implants
  • History of breast related radiotherapy treatment
  • Previous breast surgery
  • Suspected oversensitivity to light; e.g. patient who has had photodynamic

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验

Diffuse reflectance spectroscopy measurements during... | 临床试验